6-MONTH USMLE STEP 1 SAMPLE SCHEDULE

Thanks for downloading our sample schedule! We don't suggest this is the ultimate schedule, but we offer it a starting point for yo

Ultimately, we recommend using a personalized, flexible, and easily managed daily study plan like what Cram Fighter offers, to ens
Day Event Subjects
Microbiology; Pathoma tasks
Study block #1 Spinal Cord Lesions; 17.3 Meningitis;
1 Nervous
Microbiology; 17.4
begins 17.4 Cerebrovascular
Cerebrovascular DiseaseDisease (Part
(Part 2
1
2 System
Nervous of 2); 17.5 Trauma, 17.6
Microbiology;
System Disorders
Demyelinating(PartDisorders
2 of 2); 17.7(PartDementia
1 of 2)
3 Nervous
Microbiology; 17.7 Dementia andDisorders
Degenerative
and Degenerative (Part 1 of
4 System
Nervous Disorders (Part 2 of 2); 17.8 CNS
Nervous Posterior Pituitary Gland; 15.3 Thyroid
5 System
System; Tumors
Gland, 15.4 Hyperthyroidism, 15.5
Nervous Hyperthyroidism, 15.5
6 Endocrine
System; Hypothyroidism,
Hypothyroidism, 15.6 15.6 Thyroiditis,
Thyroiditis, 15.7
15.7
Nervous
Endocrine 15.9
ThyroidEndocrine
Neoplasia Pancreas;
(Part 2 15.10
of 2); 15.8
7 System;
Adrenal Cortex, 15.11 Adrenal
8 Catch-up day Endocrine
Microbiology
System; 15.10 Adrenal Cortex, 15.11 Adrenal
9 Endocrine
System; Medulla (Part 2 of 2); 7.1 Vasculitis
10 System;
Endocrine (Part 1 of 2) (Part 2 of 2)
7.1 Vasculitis
Endocrine
System; 7.2 Hypertension (HTN); 7.3
11 System;
Endocrine 7.4 Aortic Dissection and Aneurysm;
Arteriosclerosis
12 Cardiovascular
System; 7.5 Vascular Tumors; 8.1 Ischemic
Endocrine
Cardiovascular 8.1 Ischemic
Heart DiseaseHeart
(IHD)Disease
(Part 1 (IHD)
of 3)
13 System;
Endocrine 8.1
(PartIschemic
2 of 3) Heart Disease (IHD)
14 Cardiovascular
System;
Microbiology; (Part 3 of 3); 8.2 Congestive Heart
15 Cardiovascular
Cardiovascular Failure (CHF); 8.3 Congenital Defects
Cardiovascular 8.4 Valvular Disorders (Part 1 of 2)
System 8.5 Endocarditis; 8.6 Cardiomyopathy,
16 System;
Cardiovascular 8.7 Cardiac Tumors; 18.1 Skeletal
Musculoskeletal 18.1 Skeletal System (Part 2 of 2);
17 System;
Cardiovascular 18.2 Bone Tumors (Part 1 of 2)
Musculoskeletal 18.2 Bone Tumors (Part 2 of 2); 18.3
18 System;
Cardiovascular Joint
18.3 Joint
(Part (Part 2 of 2); 18.4 Skeletal
1 of 2)
19 Musculoskeletal
System; Muscle, 18.5 Neuromuscular Junction,
System;
Musculoskeletal 9.1
18.6Nasopharynx,
Soft Tissue 9.2 Larynx; 9.3
Tumors
20 Musculoskeletal
Musculoskeletal Pulmonary
9.3 Pulmonary Infections
Infections (Part(Part
1 of22)of 2);
21 System;
System; 9.4 Chronic Obstructive Pulmonary
22 Catch-up day Respiratory
Microbiology Disease (Part 1 of 3)
Musculoskeletal
9.4 Chronic Obstructive Pulmonary
23 System;
Musculoskeletal 9.4 Chronic Obstructive Pulmonary
Disease (Part 2 of 3)
24 Respiratory
System; Disease (Part 3 of 3); 9.5 Restrictive
Musculoskeletal
Respiratory 9.6 Pulmonary
Diseases (Part Hypertension,
1 of 2) 9.7
25 System;
Musculoskeletal 9.8 Lung Cancer (Part 2 of 2); 9.99.8
Respiratory Distress Syndromes;
26 Respiratory
System; Pleura; 19.1 Inflammatory
System; 19.1 Inflammatory Dermatoses (Part 2
27 Respiratory
Respiratory Dermatoses (Part 1 of
of 2); 19.2 Blistering 2)
Dermatoses;
Miscellaneous;
System; Melanocytes;
19.3 Epithelial19.5TumorsInfectious
28 12.1 Congenital (Part 2 of 2); 12.2
Skin; Renal &
Miscellaneous; Disorders; 12.1 Congenital (Part 1 of
29 Acute Renal Failure (ARF); 12.3
Renal & Urinary
Miscellaneous;
30 Nephrotic Syndrome
12.3 Nephrotic Syndrome(Part (Part
1 of 2)2 of 2)
Renal & Urinary Tract Infection, 12.6 Nephrolithiasis,
Miscellaneous;
31 Failure (Part 2 of 2); 12.8 Renal
Renal
Renal && Urinary
Urinary 12.7 Chronic Renal Failure (Part 1 of
32 Neoplasia; 12.9 Lower Urinary Tract
System;
Respiratory 4.1 Primary 4.1Hemostasis and Related
33 Carcinoma; Primary Hemostasis
Respiratory
System; Bleeding
Bleeding Disorders (Part 2
Disorders (Part 3 of
of 3)
3); 4.2
34 System;
Respiratory Secondary Hemostasis and Related
35 Hematology
System; & Related Disorders (Part 2 of 2); 4.3
Other Disorders of Hemostasis; 4.4
36 Catch-up day Hematology
Microbiology&
Respiratory
4.4 Thrombosis (Part 2 of 2); 4.5
37 System;
Renal & Urinary 4.5 Embolism
Embolism (Part(Part
1 of22)of 2); 5.1
38 Hematology & Anemia; 5.2 Microcytic Anemias Part
System;
Hematology & 1 (Part 1 of 2)
 Renal & Urinary 5.2 Microcytic Anemias Part 1 (Part 2
39 System;
Renal & Urinary of
5.22); 5.2 Microcytic
Microcytic Anemias Anemias
Part 2Part(Part2 2
40 Hematology
System; & (Part 1 of 2)
Renal & Urinary of
5.22); 5.2 Microcytic
Microcytic Anemias Anemias
Part 3Part(Part3 2
41 Hematology
System; & (Part 1 of 2)
Microbiology; of 2); 5.3 Macrocytic Anemia (Part 1
42 Hematology
Hematology & 5.3
of 2)Macrocytic Anemia (Part 2 of 2);
Microbiology;& 5.4 Normocytic Anemia
Oncology 5.5 Normocytic Anemias w/
43 Hematology
Microbiology;& Extravascular
Extravascular Hemolysis
Hemolysis (Part (Part 1 2 of
of 2)
2);
44 Oncology
Hematology & 5.6 Normocytic Anemias w/
Microbiology; Intravascular Hemolysis, 5.7 Anemia
45 Oncology
Hematology Intravascular Hemolysis,(Part 5.7 Anemia
Microbiology;& Due to Underproduction
6.1 Leukopenia and Leukocytosis 2 of 2);
46 Oncology
Hematology 6.1 Leukopenia and Leukocytosis
Hematology & & (Part 2 of 2);Leukemia
6.3 Chronic 6.2 Acute(Part
Leukemia;
2 of 2);6.3
47 Oncology
Oncology; & (MPD)Chronic Leukemia
6.4 Myeloproliferative (Part 1 of
Disorders 2)
Hematology (Part 2 of 2) ;6.5
48 Gastrointestinal
Oncology; & (MPD) (Part 1 of 2) (LAD), 6.6
Lymphadenopathy
Hematology
(HL) (Part
Gastrointestinal Lymphoma, 2 6.7
of 2); 6.8 Plasma
Hodgkin Cell
Lymphoma
49 Oncology;
Disorders (Dyscrasias), 6.9
50 Catch-up day Gastrointestinal
Microbiology
Hematology & (Dyscrasias), 6.9 Langerhans Cell
51 Oncology;
Microbiology; Histiocytosis (Part 2 of 2); 10.1 Oral
52 Gastrointestinal
Gastrointestinal Cavity; 10.2 Salivary Gland; 10.3
Gastrointestinal 10.3 Esophagus (Part 2 of 2)
53 System
System;
Gastrointestinal 10.4 Stomach (Part 1 of 2)
Reproductive 10.4 Stomach (Part 2 of 2); 10.5 Small
54 System;
Gastrointestinal 10.5
BowelSmall
(PartBowel
1 of 2)(Part 2 of 2); 10.6
55 Reproductive
System;
Gastrointestinal 10.6 Appendix, Inflammatory
Appendix, 10.7 10.7 Inflammatory Bowel
56 Reproductive
System; Disease (Part 1 of 2)
Gastrointestinal Bowel Disease
10.8 Colon (Part22of
(1) (Part of2);
2);10.8
10.8
57 Reproductive
System; Colon (1) (Part 1 of 2)
Gastrointestinal Colorectal
11.1 Exocrine Carcinoma
Pancreas (2);(Part
11.12 of 2);
58 Reproductive
System; Exocrine
11.2 Pancreas (Part 1 ofTract;
2)
System; 11.3 Gallbladder
Liver: Jaundice and(Part
Biliary 2 of 2); 11.3
59 Reproductive
Behavioral/Psy 11.3
Liver:Liver: Jaundice
Hepatitis; 11.3 (Part
Liver: 1Cirrhosis
of 2) &
System;
chiatry; 11.3
TumorsLiver:
(PartCirrhosis
1 of 2) & Tumors (Part 2
60 Behavioral/Psy
Reproductive of 2); 13.1 Vulva (Part 1 of 2)
chiatry; 13.1 Vulva (Part 2 of 2); 13.2 Vagina
61 System;
chiatry; 13.2 Vagina
(Part 1 of 2) (Part 2 of 2); 13.3 Cervix;
62 Behavioral/Psy
Biochem, Cell
Cell 13.4 Endometrium and Myometrium
Biochem,
Bio, 13.4 Endometrium and Myometrium
63 Bio, Genetics;
Genetics; (Part 1 of 3)
(Part 2 of 3)
64 Catch-up day Reproductive
Microbiology
Biochem, Cell 13.4 Endometrium and Myometrium
65 Bio, Genetics;
Biochem, Cell (Part 3 of 3); 13.5 Ovary; 13.6 Ovarian
Reproductive 13.6
TumorsOvarian
(Part Tumors
1 of 2) (Part 2 of 2); 3.5
66 Bio, Genetics;
Biochem, Cell - HHV-6, roseola (Herpesviridae)
67 Reproductive
Bio, Genetics;
Biochem, Cell 13.7 Gestational Pathology
Reproductive 14.1 Penis; 14.2 Testicle; 14.3
68 Bio, Genetics;
Biochem, Cell Testicular Tumors (Part 1 of 2)
Reproductive 14.3 Testicular Tumors (Part 2 of 2);
69 Bio, Genetics;
Biochem, Cell 16.2
14.4 Inflammatory
Prostate; 16.1Conditions;
Introduction16.3
70 Reproductive
Bio, Genetics; Benign Tumors and Fibrocystic
Biochem, Cell
71 Reproductive Changes
Bio, Genetics; 16.4 Breast Cancer (Part 1 of 2)
Reproductive
Reproductive 16.4 Breast Cancer (Part 2 of 2); 2.3
72
System;
Microbiology; Primary Immunodeficiency
2.4 Autoimmune Disorders Part 1
73 2.4 Autoimmune Disorders Part 1
Immunology
Microbiology; (Part 1 of 2)
74 (Part 2 of 2); 2.4 Autoimmune
Immunology
Microbiology; 2.4 Autoimmune Disorders Part 2
75 Disorders Part 2 (Part 1 of 3)
Immunology 2.4
(PartAutoimmune
2 of 3) Disorders Part 2
Immunology;
76 Microbiology; (Part 3 of 3); 1.1 Growth Adaptations
Pathology - 1.1
77 Pathology - (PartGrowth
1 of 2)Adaptations (Part 2 of 2);
1.2 Cellular Injury (Part 1 of 3)
78 Catch-up day General
Microbiology
Microbiology;
79 Pathology - 1.2 Cellular Injury (Part 2 of 3)
General
 Microbiology;
1.2 Cellular Injury (Part 3 of 3); 1.3
80 Pathology -
Microbiology; Cell Death
1.3 Cell (Part(Part
Death 1 of22)of 2); 1.4 Free
81 General
Pathology -
Immunology; Radical
1.4 FreeInjury
Radical (Part 1 of(Part
Injury 2) 2 of 2);
82 General
Pathology -
Immunology; 1.5 Amyloid
1.5 Amyloid (Part
(Part 2 1 of
of 2);
2) 2.1 Acute
83
Pathology
Immunology;- Inflammation Part 1
2.1 Acute Inflammation Part(Part 1 of1 3)
(Part 2
84 2.1 Acute Inflammation Part 1 (Part 3
Pathology
Immunology;- of 3)
85 Microbiology; of
2.13); 2.1 Acute
Acute Inflammation
Inflammation Part 2Part
(Part2 2
Pathology -
86 Pathology - (Part
of 1 of 2)
2.12); 2.1 Acute
Acute Inflammation
Inflammation Part 3Part
(Part3 2
Pathology
General - (Part 1 of 2)
87 of 2); 2.2 Chronic Inflammation (Part 1
General
Pathology - 2.2
88 of 2)Chronic Inflammation (Part 2 of 2);
General
General; 2.5
2.5 Wound
Wound Healing
Healing (Part
(Part 12 of
of 2)
2); 3.1
89
Pharmacology
General; - Neoplasia (Part 1 of 2)
3.1 Neoplasia (Part 2 of 2); 3.2
90 3.2 Carcinogenesis
Pathology
General; - Carcinogenesis PartPart 1 (Part
1 (Part 1 of22)of
91 2); 3.2 Carcinogenesis Part 2 (Part 1
Pathology -
92 Catch-up day of 2)
3.2 Carcinogenesis Part 2 (Part 2 of
General;
93 2);
3.2 3.2 Carcinogenesis
Carcinogenesis PartPart 3 (Part
3 (Part 2 of1
Pathology
Pathology --
94 of 2)
2); 3.3 Tumor Progression (Part 1 of
General
Pathology - 3.3
95 2) Tumor Progression (Part 2 of 2);
General 3.4 Clinical Characteristics
96 Catch-up day Spinal Cord Lesions; 17.3 Meningitis;
Study block #2 Nervous
97 17.4 Cerebrovascular Disease; 17.5
begins System
Nervous Disorders (PartDemyelinating
2 of 2); 17.7 Dementia
98 Trauma, 17.6
System Tumors;
and 15.1 Anterior
Degenerative Pituitary
Disorders Gland,
(Part 1 of
System;
99 15.2 Posterior Pituitary Gland; 15.3
Endocrine
System; Hypothyroidism, 15.6Hyperthyroidism,
Thyroiditis, 15.7
100 Thyroid Gland, 15.4
Endocrine
Endocrine Thyroid Neoplasia (Part
15.10 Adrenal Cortex, 15.11 2 of 2); 15.8
Adrenal
101
System; Medulla; 7.1 Vasculitis (Part 1 of 2)
102 Catch-up Day 7.1 Vasculitis (Part 2 of 2); 7.2
Endocrine
103 Hypertension
7.4 (HTN); and
Aortic Dissection 7.3 Aneurysm;
System;
System;
104 Arteriosclerosis
7.5 Vascular Tumors; 8.1 Ischemic
Cardiovascular
System; (Part
105 Heart2Disease
of 2); 8.2 Congestive
(IHD) (Part 1 ofHeart
2)
Cardiovascular
System; Failure (CHF); 8.3 Congenital
8.5 Endocarditis; 8.6 Cardiomyopathy, Defects;
106 18.1 SkeletalTumors;
System18.1 (PartSkeletal
2 of 2);
Musculoskeletal
System; 8.7 Cardiac
107 18.2 Bone Tumors; 18.3 Joint
Muscle, 18.5 Neuromuscular Junction, (Part 1
Musculoskeletal
Musculoskeletal of 2)
108 18.6 Soft Tissue
9.3 Pulmonary Tumors; (Part
Infections 9.1 2 of 2);
System;
Musculoskeletal Nasopharynx, 9.2 Larynx; 9.3
109 9.4
9.4 Chronic
Chronic Obstructive
Obstructive Pulmonary
Pulmonary
System;
System;
110 Disease
Disease (Part 1
(Part 2 of
of 2)
2); 9.5 Restrictive
Respiratory
System; 9.6 Pulmonary
111 Diseases (Part Hypertension,
1 of 2) 9.7
Respiratory Blistering
Respiratory Dermatoses; 19.3 Epithelial
Distress Syndromes; 9.8
Musculoskeletal
112 System; Tumors;
Melanocytes19.4(Part
Disorders
2 of of 19.5
2);
System; Skin
113 Miscellaneous; Pigmentation and Melanocytes (Part 1
Miscellaneous; Infectious Disorders;
2); 12.4 Nephritic 12.1 Congenital;
Syndrome; 12.5
114 Skin;
RenalRenal & 12.2
& Urinary Acute
Urinary Renal
Tract Failure (ARF); 12.3
Failure (Part 2Infection,
of 2); 12.812.6
Renal
;Renal
System & Nephrolithiasis,
115 Neoplasia; 12.9 12.7 Lower Chronic
UrinaryRenal
Tract
Urinary
116 Catch-up day Carcinoma; 4.1 Primary Hemostasis
System; Bleeding Disorders (Part 2 of 2); 4.2
117
Hematology
& Urinary & Secondary Hemostasis
Related Disorders (Part and
2 of Related
2); 4.3
118 4.5 Embolism; 5.1 Anemia; 5.2 4.4
System;
System; Other Disorders of Hemostasis;
119 Microcytic Anemias Part 1 (Part 1 of
Hematology
System; & of 2); 5.2 Microcytic Anemias Part 2;
120 2)
Hematology & 5.2 Microcytic Anemias Part 3 (Part 1
 5.2 Microcytic Anemias Part 3 (Part 2
Hematology &
121 of 2); 5.3 Macrocytic
Extravascular Anemia;
Hemolysis; 5.6 5.4
Oncology
Hematology &
122 Normocytic
Normocytic Anemia
Oncology & IntravascularAnemias
Hemolysis,w/ Intravascular
5.7 Anemia
Hematology Hemolysis,
123 Due to UnderproductionDue
5.7 Anemia (Partto2 of 2);
Oncology
Oncology; Chronic Leukemia;
124 6.1 Leukopenia and6.4
Leukocytosis; 6.2
Gastrointestinal (MPD) (Part 2 of 2);
Myeloproliferative 6.5
Disorders (MPD)
Oncology;
125 Lymphadenopathy (LAD), 6.6
(Dyscrasias), 6.9 Langerhans Cell
Gastrointestinal
Oncology;
126 Lymphoma,
Histiocytosis;6.7
10.1Hodgkin Lymphoma
Oral Cavity; 10.2
Gastrointestinal
System; 10.3 Esophagus (Part 2 of 2); 10.4
127 Salivary Gland; 10.3 Esophagus (Part
Reproductive
System; Stomach (Part (Part
10.4 Stomach 1 of 2)
2 of 2); 10.5 Small
128
Reproductive
System; Bowel
10.6 Appendix, 10.7 Inflammatory
129
Reproductive Bowel Disease; 10.8 Colon (1)
130 Catch-up day
System; Exocrine Pancreas; 11.2 Gallbladder
131 11.3 Liver: Jaundice (Part 2 of 2); 11.3
Reproductive
Behavioral/Psy and Biliary Tract; 11.3 Liver: Jaundice
132 Liver: Hepatitis; 11.3 Liver: Cirrhosis &
chiatry;
System; 13.1 Vulva (Part 2 of(Part
2); 13.2
133 Tumors; 13.1 Vulva 1 ofVagina;
2)
Behavioral/Psy 13.3 Cervix (Part 1 of 2)
Behavioral/Psy 13.3 Cervix (Part 2 of 2); 13.4
134
chiatry;
Bio, Genetics; Endometrium and Myometrium
135 13.5 Ovary; 13.6 Ovarian Tumors
Reproductive
Bio, Genetics; 13.7 Gestational Pathology; 14.1
136 14.3 Testicular Tumors; 14.4 Prostate;
Reproductive
Bio, Genetics; Penis; 14.2 Testicle
137 16.1
16.3 Introduction;
Benign Tumors 16.2
andInflammatory
Fibrocystic
Reproductive
Bio, Genetics; Conditions
138 Changes; 16.4 Breast Cancer (Part 1
Reproductive Primary Immunodeficiency; 2.4
Microbiology;
139 of 2)
Reproductive 2.4 Autoimmune Disorders Part 1
Microbiology; Autoimmune Disorders Part 1 (Part 1
140 (Part 2 of 2); 2.4 Autoimmune
2.4 Autoimmune Disorders Part 2
Immunology
Immunology;
141 Disorders
(Part 2 of Part
2); 2 (Part
1.1 Growth 1 of 2)
Adaptations
Microbiology;
Pathology- 1.1 Growth
(Part 1 of 2) Adaptations (Part 2 of 2);
142 Pathology-
Microbiology; 1.2 Cellular Injury (Part 1 of 2)
General 1.2 Cellular Injury (Part 2 of 2); 1.3
143 Pathology-
Cell Death (Part 1 of 2)
144 Catch-up day General
Microbiology; 1.3 Cell Death (Part 2 of 2); 1.4 Free
145 Pathology- Radical Injury; 1.5 Amyloid (Part 1 of
Immunology;
General 1.5
2) Amyloid (Part 2 of 2); 2.1 Acute
146 Immunology;
Pathology- Inflammation
of 2); 2.1 Acute Part 1 (Part 1 ofPart
Inflammation 2) 2;
147 Pathology-
Immunology; 2.1
2.1 Acute
Acute Inflammation
Inflammation Part Part 3
3 (Part
(Part 1 2
148 General
Pathology-
Pathology- of 2); 2.2 Chronic Inflammation
2.5 Wound Healing; 3.1 Neoplasia
149 General
General
General; (Part 1 of 2) (Part 2 of 2); 3.2
3.1 Neoplasia
150
Pharmacology-
General; Carcinogenesis
3.2 Carcinogenesis PartPart
1 2; 3.2
151 3.2 Carcinogenesis Part 3 (Part
Pharmacology-
General; Carcinogenesis Part 3 (Part 1 of22)of
152 2); 3.3 Tumor Progression; 3.4
Study block #3 Pharmacology- 17.4 Cerebrovascular Disease; 17.5
Nervous
153 Clinical Characteristics
begins System 15.2 Posterior
Trauma, Pituitary Gland; 15.3
17.6 Demyelinating
System;
154 Thyroid Gland,
2); 15.10 Adrenal 15.4 Hyperthyroidism,
Cortex, 15.11
Endocrine
Endocrine
155 15.5 Hypothyroidism,
Adrenal 15.6 Thyroiditis,
System; Aortic Dissection and Aneurysm;7.2
Medulla; 7.1 Vasculitis; 7.5
System; Hypertension (HTN); 7.3
156 Vascular Tumors; 8.1 Ischemic
Endocarditis; 8.6 Cardiomyopathy, 8.7 Heart
Cardiovascular
System;
157 Disease
Cardiac (IHD); 8.2
Tumors; Congestive
18.1 Skeletal Heart
Musculoskeletal Neuromuscular Junction, 18.6 Soft
Musculoskeletal System; 18.2 Bone Tumors (Part 1 of
158 Tissue
DiseaseTumors;
(Part 2 of 9.12);
Nasopharynx,
9.5 Restrictive9.2
System;
System;
159 Larynx; 9.3 Pulmonary
Diseases;Dermatoses;
9.6 Pulmonary Infections; 9.4
Miscellaneous;
Respiratory Blistering 19.3 Epithelial
160 Respiratory Hypertension,
Tumors; 9.7 Respiratory
Miscellaneous; Infection,19.4
12.6Disorders of
Nephrolithiasis, 12.7
161 System;
Renal Skin; Pigmentation
& Urinary and
Chronic Renal Failure Melanocytes; 19.5
System
 System; Renal Urinary Tract Carcinoma; 4.1 Primary
162 & Urinary Hemostasis and Related Bleeding
& Urinary
System; 4.4 Thrombosis;
Disorders; 4.5 Embolism;
4.2 Secondary 5.1
Hemostasis
163
System;
System; Anemia; 5.2
Microcytic Microcytic
Anemias PartAnemias
3; 5.3 Part
164 Normocytic Anemias5.4 w/ Normocytic
Intravascular
Hematology &
Hematology & Macrocytic Anemia;
165 Hemolysis, 5.7 Anemia Due to
Oncology
Oncology; Myeloproliferative Disorders (MPD);
166 Underproduction; 6.1 Leukopenia and
(Dyscrasias),
Gastrointestinal 6.9 Langerhans
6.5 Lymphadenopathy (LAD), Cell
6.6
Oncology;
167 Histiocytosis; 10.1 Oral Cavity; 10.2
Gastrointestinal
System; Bowel;
168 Salivary10.6 Appendix,
Gland; 10.7
10.3 Esophagus; 10.4
Reproductive
System; Inflammatory Bowel Disease;
Exocrine Pancreas; 11.2 Gallbladder 10.8
169
Reproductive
Behavioral/Psy and
of 2);Biliary Tract; 11.3
13.1 Vulva; 13.2Liver: Jaundice;
Vagina; 13.3
170 13.4 Endometrium and Myometrium
chiatry;
Biochem, Cell Cervix; 13.4 Endometrium and
171 (Part 2 of 2); 13.5 Ovary; 13.6 Ovarian
Bio, Genetic;
172 Catch-up day Tumors; 13.7 Gestational Pathology
Testicular Tumors; 14.4 Prostate; 16.1
Bio, Genetic;
173 Introduction; 16.2 Inflammatory
16.4 Breast Cancer; 2.3 Primary
Reproductive
Microbiology; Conditions; 16.3 Benign Tumors and
174 Immunodeficiency;
2.4 Autoimmune Disorders2.4 Autoimmune
Part 2; 1.1
Reproductive
Immunology;
175 Disorders
Growth Part 1
Adaptations; 1.2 Cellular
Microbiology;
Pathology-
176 Pathology- Injury (Part 1Injury
1.2 Cellular of 2) (Part 2 of 2); 1.3 Cel
Immunology;
General 1.4 Free Radical Injury; 1.5 Amyloid;
177 Immunology;
Pathology- 2.1
AcuteAcute Inflammation
Inflammation PartPart 1
3; 2.2
178 Pathology-
General; Chronic
2.5 Wound Inflammation;
Healing (Part2.52Wound
of 2); 3.1
179 General
Pharmacology - Carcinogenesis
General; Neoplasia; 3.2 Carcinogenesis
Part 3; 3.3 Tumor Part 1
180
Pharmacology- Progression; 3.4 Clinical
hedule, but we offer it a starting point for your plan. Remember, everyone learns differently, and you will need to adjust your plan for your weak a

dy plan like what Cram Fighter offers, to ensure you cover all the Step 1 exam material you need to. Access a 7-day FREE trial of the Cram Fighte
SketchyMicro tasks First Aid (2021)
Embryology tasks
pp. 504-506; Pages Lecture length
1.1 - Staphylococcus aureus (Part
2 Anatomy & Physiology (Part 8 34 minutes
1 of
of 2);
2) 1.2 - Staphylococcus Anatomy & Physiology (Part
epidermidis & saprophyticus; 1.3 - 1 of 3) pp. 507-511 8 34 minutes
1.3 - Streptococcus pyogenes 2 of 3) pp. 512-519
Streptococcus pyogenes (group A Anatomy & Physiology (Part 8 34 minutes
(group A strep)agalactiae
Streptococcus (Part 2 of 3) (group B 3 of 3) pp. (Part
Pathology 520-527
1 of 3) pp.
8 34 minutes
strep); 1.5 - Streptococcus
& viridans (Part 2 of 2); 1.6 - 528-535
Pathology (Part 2 of 3) pp.
1.6 - Enterococcus faecium & Pathology 8 34 minutes
Enterococcus faecium & faecalis 536-543 (Part 3 of 3) pp.
faecalis (Part 2 of 2); 2.1 - Bacillus Otology 544-550;(Part
Otology
2 of (Part
2) pp.1552-
of 8 33 minutes
(Part
anthracis2 of & 2);cereus
2.2 - Clostridium
(Part 1 of 2) 2) pp. 551-551
2.3 - Clostridium
tetani; botulinum
2.3 - Clostridium (Part 2 552; Ophthalmology (Part 1
botulinum
8 34 minutes
of 2); 2.5 - Clostridioides Difficile of 2) pp. 553-559 10 minutes
2.5 - Clostridioides Difficile (Part 2 Ophthalmology (Part 2 of 2)
(Part
of 12.5
of -2)Clostridium perfringens pp. 560-563; Pharmacology
2.52);- Clostridium perfringens (Part 8 34 minutes
(Part 1 of 2)- Corynebacterium pp.
(Part568-573; Embryology
1 of 2) pp. 564-567 pp.
2 of 2); 2.6
2.7 - Listeria monocytogenes; 3.1 334-334; Anatomy pp. 335- 8 33 minutes
diphtheriae Physiology (Part 1 of 2) pp.
- Actinomyces israelii; 3.2 - Physiology (Part 2 of 2) pp. 8 35 minutes
of 2); 4.1 -asteroides
Nocardia Neisseria (Partoverview; 4.2 336-343
1 of 2)
4.2 - Neisseria meningitidis 344-345; Pathology (Part 1 of 8 33 minutes
- Neisseria meningitidis (Part(Part
1 of2 Pathology (Part 2 of 3) pp.
of 2); 4.3 - Neisseria gonorrhoeae 3) pp. 346-351 8 34 minutes
2 of 2); 5.12)- Klebsiella 352-359
360-361; Pharmacology pp.
(Part 1 of 8 34 minutes
pneumoniae, spp.,
Enterobacter Enterobacter
Serratia spp., 290-291;
362-365; Anatomy
Embryology pp.(Part
292- 1
5.3 - Shigella spp.; 5.4 - 8 34 minutes
marcescens (Part 2 of 2); ; 5.2 - Physiology 292; Physiology
(Part (Part 1 of
2 of 2) pp.2)
Escherichia
5.4 - Escherichia coli (ETEC,
coli (ETEC,EHEC) 8 33 minutes
298-305
(Part
EHEC) 1 of 2) 2 of 2); 5.5 - Yersinia Pathology (Part 1 of 3) pp.
(Part 8 34 minutes
pestis (Part 2 & of pestis
2); 5.6(Part
- 306-313
enterocolitica 1 of 2) Pathology (Part 2 of 3) pp. 8 34 minutes
Campylobacter Pathology (Part 3 of 3) pp.
5.7 - Vibrio spp.jejuni; (Part 25.7 of -2);
Vibrio
5.8 - 314-321
322-323; Pharmacology (Part 8 32 minutes
Helicobacter
5.9 - Proteus pylori mirabilis; 6.1 - pp.
1 of330-332; Anatomy &
2) pp. 324-329 8 36 minutes
6.1 - Bordetella
Bordetella pertussis
pertussis (Part (Part
1 of 2)2 Physiology (Part 1 of 2) pp.
Anatomy & Physiology (Part
of 2);
6.3 6.2 - Haemophilus
- Legionella pneumophila; 6.4 2 of 2) pp. 461-468 8 33 minutes
influenzae
- Pseudomonas aeruginosa (Part 10 minutes
6.4 - Pseudomonas aeruginosa
1 of 2)2 of 2); 7.1 - Bartonella Pathology (Part 1 of 3) pp.
(Part
7.1 - Bartonella henselae (Part 2 469-476 8 34 minutes
henselae Pathology (Part 2 of 3) pp.
of 2); 7.2 -(Part 1 of 2)
Brucella spp.; 7.3 - Pathology 8 34 minutes
of 2); 7.4 - Pasteurella multocida; 477-484 (Part 3 of 3) pp.
Francisella tularensis (Part 1 of 2) 485-485; Dermatology (Part 1 8 34 minutes
8.1 Dermatology (Part 2 of 2) pp.
8.1 -- Mycobacterium
Mycobacterium tuberculosis
tuberculosis of 2) pp. 487-492
8.1
(Part- Mycobacterium
2 of 3) tuberculosis 493-498; Pharmacology (Part 8 34 minutes
pp. 500-502; Public Health
(Part 3 of 3); 8.2 - Mycobacterium 1 of 2) pp. 499-500 8 33 minutes
2 of 2);(Part
9.1 - 1Borrelia Sciences (Part 1 of 4) pp.
leprae of 2) burgdorferi; Public Health Sciences (Part 8 34 minutes
9.2 - Leptospira interrogans
9.2 - Leptospira interrogans (Part 2 (Part of 4) Health
pp. 265-272
Public Sciences (Part
2
ofof2);2); 9.3--Chlamydia
10.1 Treponema pallidum 8 34 minutes
3 of 4) pp. 273-280
Approaching the Organ
(Part 1 of 2) Chlamydophila
trachomatis, 8 32 minutes
Chlamydophila pneumoniae & Systems
Rapid pp. 284-285;
Review (Part 2 of Rapid
4)
pneumoniae & Chlamydophila 8 35 minutes
Chlamydophila
Chlamydophila pneumoniae psittaci (Part & 2 of pp. 718-725
Rapid Review (Part 3 of 4)
Chlamydophila psittaci (Part 3 of Rapid Review (Part 4 of 4) 8 34 minutes
2 pp. 726-733
3);of10.2
2); 10.4 - Mycoplasma
- Coxiella burnetii; 10.3 - pp. 734-735; Respiratory 8 34 minutes
10.5 - Rickettsia
pneumoniae; 10.5 overview
- Rickettsia(Part 2
Respiratory (Part 2 of 4) pp.
of 2); 10.6 - Rickettsia prowazekii; (Part 1 of 4) pp. 683-688 8 34 minutes
689-696
Respiratory (Part 3 of 4) pp.
10.7
1.1 - -Histoplasma
Rickettsia rickettsii
capsulatum 8 34 minutes
1.2 - Blastomyces dermatitidis; 1.3 697-704
10 minutes
-ofCoccidioides immitis (Part 1 of 2) Respiratory (Part 4 of 4) pp.
2); 1.4 - Paracoccidioides
2); 2.2 - Epidermophyton spp., 8 33 minutes
brasiliensis; 2.1 - Malassezia 705-712
Anatomy pp. 604-604;
Trichophyton spp., Microsporum 8 34 minutes
Physiology (Part 1 of 2) pp.
spp. (dermatophytes); 2.3 -
2.3 - Sporothrix schenckii (Part 2
Physiology (Part 2 of 2) pp.
of
3.12); 3.1 - Candida
- Candida albicans albicans
(Part 2(Part
of 610-617 8 34 minutes
1 of 2) - Aspergillus fumigatus Pathology (Part 1 of 2) pp.
2);
3.2 3.2- Aspergillus fumigatus (Part 2 Pathology 8 34 minutes
618-625 (Part 2 of 2) pp.
(Part
of 2); 13.3 of -2)Cryptococcus 626-629; Pharmacology pp. 8 34 minutes
(Part
neoformans2 of 2);(Part3.4 - 1Mucor
of 2) spp., Anatomy
630-633 pp. 416-419;
(mucormycetes) (Part 2 of 2); 3.5 Physiology 8 32 minutes
Rhizopus spp. (mucormycetes) Physiology (Part
(Part 21 of
of 2)
2) pp.
pp.
-1.1Pneumocystis jirovecii;
- Picornaviridae overview (Part 1.1 - 422-423; Pathology (Part 1 of 8 35 minutes
Picornaviridae overview (Part 1 of Pathology
3) pp. (Part 2 of 3) pp.
424-429
2 of 2); 1.2 - Poliovirus Pathology (Part 3 of 3) pp. 8 34 minutes
(Part 2 of 2); 1.3(Part - Coxsackievirus 430-437
(Picornaviridae) 1 of 2)
(Picornaviridae)
A & B (Picornaviridae) (Part 2(Part
of 2);1 of1.4 438-444; Pharmacology (Part 8 34 minutes
Pharmacology (Part 2 of 3)
-(Picornaviridae)
Rhinovirus (Picornaviridae);
(Part 2 of 2); 1.6 1.5 -- 1 of 3) pp. 445-445 8 33 minutes
pp.
pp. 446-453
454-454; Embryology pp.
Hepatitis A virus (Picornaviridae)
Norovirus/Norwalk virus (Part 2 Anatomy (Part 2 of 2) pp. 8 34 minutes
1.7 - Flaviviridae overview 368-369; Anatomy (Part 1 of
(Caliciviridae);
of 2); 1.8 - Hepatitis 1.7 - Flaviviridae
(Flaviviridae) (Part 2Cofvirus2); 1.9 - 375-380; Physiology
Physiology (Part 2 of (Part
2) pp.1 8 34 minutes
(Flaviviridae) (Part 1 of 2)
Eastern/Western/Venezuelan of 2) pp. 381-382
383-385; Pathology (Part 1 of 8 34 minutes
equine encephalitis virus, Rubella
equine
virus encephalitis(Part
(Togaviridae) virus,2Rubella
of 2); 4) pp. 386-390 10 minutes
1.10
1.10 -- Coronavirus
Coronavirus Pathology (Part 2 of 4) pp.
8 34 minutes
(Coronaviridae) (Part
1.11 - HIV Part 1: Overview 2 of 2) 391-398
Pathology (Part 3 of 4) pp.
1.11 - HIV Part 1: Overview 8 31 minutes
(Retroviridae) (Part 1 of 2) 399-406
407-407; Pharmacology pp.
(Retroviridae)
1.12 - HIV Part(Part 2: Life2 of 2); 1.12
Cycle (Part- 408-411; Embryology (Part 1 8 36 minutes
HIV
2 of Part
2); 2.1 2: -Life Cycle (Part 1 of 2) Embryology (Part 2 of 3) pp.
Influenzavirus 8 34 minutes
2.1 - Influenzavirus (Part 1 of 3) 639-646
(Orthomyxoviridae) 647-647; Anatomy pp. 648-
8 34 minutes
(Orthomyxoviridae)
2.2 - Measles virus, (Part mumps 3) Physiology
2 ofvirus, (Part (Part
652; Physiology 2 of 2) pp.2)
1 of
655-660; Pathology (Part 1 of 8 33 minutes
respiratory syncytial
respiratory syncytial virus,
virus, Pathology (Part 2 of 3) pp.
3) pp. 661-662 8 34 minutes
parainfluenza
parainfluenza virus virus 663-670
Pathology (Part 3 of 3) pp.
Pharmacology pp. 679-682; 8 34 minutes
(Paramyxoviridae) (Part
Marburgvirus (Filoviridae); 2.5 - 3 of 3); 671-678
Psychiatry (Part 1 of 4) pp. 8 34 minutes
Hantavirus, California(Part
virus (Bunyaviridae) encephalitis
2 of 2) ; Psychiatry
575-578 (Part 2 of 4) pp. 8 34 minutes
2.6 - Lymphocytic
fever virus (Reoviridae); 3.1 - 579-586
Psychiatry (Part 3 of 4) pp.
Psychiatry (Part 4 of 4) pp. 8 33 minutes
Herpes
& 2 (Herpesviridae) (Part 2 of 2); 587-594
simplex virus type 1 & 2
595-600; Molecular (Part 1 of 8 34 minutes
3.2
3.2 -- Epstein–Barr
Epstein–Barr virus virus Molecular (Part 2 of 3) pp.
3) pp. 34-35 8 34 minutes
(Herpesviridae) (Part 2
(Herpesviridae) (Part 3 of 3); 3.3 -of 3) 36-43
10 minutes
Cytomegalovirus
(Herpesviridae) (Part (Herpesviridae)
2 of 2); 3.4 - Molecular (Part 3 of 3) pp.
Laboratory Techniques 8 34 minutes
Varicella-zoster virus
3.4 - Varicella-zoster virus 34-35; Cellular pp. 46-51pp.
52-55;
Genetics (Part 2 (Part
Genetics of 2) 1 of60-
pp. 2) 8 32 minutes
(Herpesviridae)
(Herpesviridae);(Part 3.7 - 2JC of 2)
pp.
64; 56-59
Nutrition
polyomavirus
polyomavirus,(Polyomaviridae)
BK polyomavirus Nutrition (Part(Part
2 of12)ofpp.
2) pp.
68- 8 34 minutes
(Part 2 of 2); 3.8 - Human 65-67
72; Metabolism (Part 1 of 4) 8 35 minutes
(Papillomaviridae) (Part 2 of 2);
papillomavirus (Papillomaviridae) Metabolism
pp. 73-75 (Part 2 of 4) pp.
3.9 8 33 minutes
3.9 -- Parvovirus
Parvovirus B19 B19 76-83
Metabolism (Part 3 of 4) pp.
(Parvoviridae)
virus, Molluscum (Part 2 of 2); 3.10 - Metabolism (Part 4 of 4) pp.
contagiosum 8 34 minutes
84-91
Adenovirus (Adenoviridae)
virus (Poxviridae); 3.12 - Hepatitis 92-94; Basic Bateriology 8 34 minutes
3.12
B virus- Hepatitis B virus (Part 1 2)
(Hepadnaviridae) pp.1129-133;
(Part of 2) pp. Clinical
124-128
3.12 - Hepatitis B (Part virus 2 of 3) 8 32 minutes
(Hepadnaviridae) Bacteriology (Part 1 of
Clinical Bacteriology 3) pp.
(Part 2
(Hepadnaviridae) (Part 3 of 3); 1.1 Clinical Bacteriology (Part 3 8 36 minutes
1.1 - Giardia lamblia of 3) pp. 137-144
- Giardia lamblia (Part(Part
1 of22)of 2); of 3) pp. 145-150; Mycology 8 34 minutes
1.2 - Entamoeba histolytica Mycology (Part 2 of 2) pp.
1.3 - Cryptosporidium spp.; 2.1 - (Part 1 of 2) pp. 151-152
2.1 - Toxoplasma
Toxoplasma gondiigondii
(Part (Part
1 of 2)2 of 153-154; Parasitology
Parasitology (Part 2 of (Part
2) pp.1 8 34 minutes
of 2) pp.
2); 2.2 - Trypanosoma brucei; 2.3 161-161; Virology (Part 1 of155-160 8 33 minutes
2.3 - Naegleria
- Naegleria fowleri
fowleri (Part(Part
1 of22)of Virology (Part 2 of 3) pp. 169-
3) pp. 162-168 8 34 minutes
2); 3.1 - Trypanosoma
3.2 - Babesia; 3.3 - Plasmodium cruzi 176
10 minutes
Part (Part 1 of 2)Part 1 (Part 2 of Virology (Part 3 of 3) pp. 177-
3.3 - 1Plasmodium
177; Systems (Part 1 of 2) 8 34 minutes
2)
pp. 178-184
 Systems (Part 2 of 2) pp.
Treatment and PPX; 3.5 -
185-186; Antimicrobials (Part 8 34 minutes
Leishmania braziliensis
donovani (Part & -
2 of 2); 4.1 Antimicrobials (Part 2 of 3)
1 of 3) pp. 187-192 8 34 minutes
vermicularis, Ancylostoma
Trichomonas Vaginalis (Part 1 of Antimicrobials
pp. 193-200 (Part 3 of 3)
duodenale,
StrongyloidesNecator americanus,
stercoralis, pp. 201-204; Immunology 8 33 minutes
Ascaris lumbricoides, Immunology (Part
(Part 1 of 4) pp. 2 of 4) pp.
95-98
Trichinella
Wuchereriaspiralis (Part
bancrofti, 2 of 2);
Onchocerca 8 34 minutes
99-106
Immunology (Part 3 of 4) pp.
5.2 - Dracunculus medinensis,
volvulus, Toxocara canis, Loa loa 8 34 minutes
6.1 - Cestodes (Part(Part
2 of 2); 107-114
(tissue nematodes) 2 of6.2
2);- Immunology (Part 4 of 4) pp.
8 34 minutes
Trematodes (Part 1 of 2) 115-122
Pathology (Part 1 of 4) pp.
6.2 - Trematodes (Part 2 of 2) 8 31 minutes
205-212
Pathology (Part 2 of 4) pp.
8 24 minutes
213-220
Pathology (Part 3 of 4) pp.
Pathology 8 24 minutes
221-228 (Part 4 of 4) pp.
229-229; Pharmacology (Part 8 24 minutes
Pharmacology (Part 2 of 4)
1 of 4) pp. 231-237 8 24 minutes
pp. 238-245
Pharmacology (Part 3 of 4)
8 23 minutes
pp. 246-253
Pharmacology (Part 4 of 4)
5 24 minutes
pp. 254-258
24 minutes
23 minutes
Embryology pp. 504-506;
Anatomy & Physiology (Part 13 41 minutes
2
1 of
of 2)
2) pp.
pp. 517-527;
507-516 13 41 minutes
Pathology
Pathology (Part
(Part 1
2 of
of 3)
3) pp.
pp.
13 38 minutes
530-542
543-550; Otology pp. 551-
Ophthalmology (Part (Part
2 of 2) 13 40 minutes
552; Ophthalmology 1
pp. 556-563; Pharmacology 12 40 minutes
(Part 1 of 2) pp. 564-567
pp. 568-573; Embryology pp.
334-334; Anatomy
Physiology pp.2)335-
(Part 2 of pp. 13 37 minutes
335; Physiology
341-345; Pathology (Part 1 of 2)
Pathology (Part 2 of (Part
2) pp.1 of 13 44 minutes
2) pp. 346-353
354-361; Pharmacology pp. 12 40 minutes
Anatomy
362-365 pp. 292-292;
Physiology 13 40 minutes
Physiology (Part
(Part 21 of
of 2)
2) pp.
pp.
301-305;
Pathology (Part 2 of 2) pp.1 of
Pathology (Part 13 41 minutes
2) pp. 306-313
314-323; Pharmacology (Part 13 40 minutes
pp.
1 of327-332; Anatomy &
2) pp. 324-326 13 40 minutes
Physiology (Part
2 of 2) pp. 463-468; 1 of 2) pp.
12 40 minutes
Pathology
Pathology (Part
(Part 1
2 of
of 2)
2) pp.
pp.
Dermatology pp. 487-498; 12 39 minutes
475-486
Pharmacology (Part 1 of 2) 14 42 minutes
pp.
pp. 501-502;
499-500 Public Health 12 40 minutes
Sciences (PartSciences
Public Health 1 of 2) pp.(Part
13 40 minutes
2 of 2) pp. 269-281
Systems pp. 284-285;
13 41 minutes
Respiratory (Part 1 of 3) pp.
Respiratory (Part 2 of 3) pp.
707-712; Embryology pp. 13 40 minutes
694-706
602-603; Anatomy
Physiology pp.2);
(Part 2 of 604- 12 39 minutes
604; Physiology
Pathology (Part (Part
(Part 2
1 of
of 2)1 of 2)
2) pp.
pp. 13 41 minutes
Pathology
618-620 Pharmacology pp.
621-629; 13 41 minutes
630-633
 Anatomy pp. 416-419;
Physiology pp. 420-423; 13 40 minutes
Pathology
Pathology (Part(Part 2 1 of
of 3)
3) pp.
pp.
Pathology 12 40 minutes
427-438 (Part 3 of 3) pp.
439-444; Pharmacology (Part 13 40 minutes
Embryology pp. 368-369;
1 of 2) pp. 445-451 13 41 minutes
Anatomy (Part
378-380; Physiology 1 of 2)pp.
pp.381-
12 36 minutes
385; Pathology
Pathology (Part (Part 1 of
2 of 3) pp.3)
13 44 minutes
390-402
403-407; Pharmacology pp.
Embryology (Part 2 of (Part
2) pp.1 13 40 minutes
408-411; Embryology
640-647; Anatomy
Physiology pp. 653-660; pp. 648- 13 38 minutes
652
Pathology (Part 1 of 3) pp. 12 41 minutes
661-664
Pathology (Part 2 of 3) pp.
13 42 minutes
665-677
678-678; Pharmacology pp.
13 40 minutes
679-682;
PsychiatryPsychiatry
(Part 2 of (Part
3) pp.1
Psychiatry (Part 3 of 3) pp. 13 41 minutes
583-595
596-600; Molecular (Part 1 of 12 38 minutes
41-45; Cellular pp. 46-51;
2) pp. 34-40 13 42 minutes
Laboratory Techniques
2 of 2) pp. 54-55; (Part
Genetics
Nutrition (Part 2 of 2) pp. 67- 13 40 minutes
pp. 56-64; Nutrition (Part 1 of
72; Metabolism (Part 1 of 3) 13 41 minutes
Metabolism
pp. 73-79 (Part 2 of 3) pp.
Metabolism (Part 3 of 3) pp. 12 41 minutes
80-91
92-94; Basic Bateriology pp. 13 40 minutes
Clinical
124-133Bacteriology (Part 1 13 40 minutes
of
of 2)
2) pp.
pp. 134-146
147-150; Mycology
Parasitology 12 41 minutes
pp. 151-154; (Part 2 of 2) pp.
Parasitology
159-161;
Virology (Part 2 of 2) pp.1172-
Virology (Part of 13 40 minutes
2) pp. 162-171
177; Systems (Part 1 of 2) 13 40 minutes
pp. 178-184
Systems (Part 2 of 2) pp.
185-186; Antimicrobials
Antimicrobials (Part 2 of (Part
2) 13 40 minutes
1 of198-204;
pp. 2) pp. 187-197
Immunology 12 41 minutes
Immunology
(Part 1 of 3) pp. (Part 2 of 3) pp.
95-99
Immunology (Part 3 of 3) pp. 13 40 minutes
100-112
113-122; Pathology (Part 1 of 13 37 minutes
Pathology
3) pp. 205-207 (Part 2 of 3) pp.
Pathology 13 43 minutes
208-220 (Part 3 of 3) pp.
221-229; Pharmacology (Part 12 41 minutes
Pharmacology
1 of 3) pp. 231-233 (Part 2 of 3)
13 40 minutes
pp. 234-246
Pharmacology (Part 3 of 3)
Staphylococcus epidermidis & Embryology 12 39 minutes
pp. 247-258 pp. 504-506;
saprophyticus;
Streptococcus agalactiae (group B Anatomy & Physiology pp.
1.3 - 24 1 hour
Streptococcus pyogenes (group A Otology
strep); 1.5 - Streptococcus 507-527 pp. 551-552; 28 1 hour
Clostridium Ophthalmology (Part 1 of 2)
pneumoniaebotulinum;
& viridans;2.5 1.6- - pp. 564-573; Embryology pp.
25 1 hour
monocytogenes; 3.1 - 2.5 -
Clostridioides Difficile; 334-334; Anatomy pp. 335-
341-345; Pathology pp. 346-
Actinomyces
Enterobacter israelii; 3.2 -
spp., Serratia Anatomy pp. 292-292; 25 1 hour
361; Pharmacology pp. 362-
Nocardia
marcescens; asteroides;
5.2 - 4.1 -
Salmonella Physiology pp. 293-305; 26 1 hour
EHEC) (Part 2 of 2); 5.5 - Yersinia 314-323; Pharmacology pp.
enteritidis & typhi;
enterocolitica 5.3 - 5.6
& pestis; Shigella
- Pathology
324-332; (Part 1 of&2) pp.
Anatomy 25 1 hour
Anatomy & Physiology (Part
Haemophilus influenzae; 6.3 -
Campylobacter jejuni; 5.7 - Vibrio Physiology (Part 1 of 2) pp.
Mycobacterium tuberculosis 2 of 2) pp. 462-468; 25 1 hour
Legionella pneumophila; 6.4 (Part
- Pharmacology
1 of 2)2 of 2); 8.2 - Mycobacterium Pathology pp. pp. 499-502;
469-486 26 1 hour
(Part ReviewHealth
Public (Part 1Sciences
of 2) pp.(Part
713-
leprae; 9.1 - Borrelia burgdorferi; 722 25 1 hour
9.2 - Leptospira interrogans; 9.3 -
of 2); 10.1 - Chlamydia Rapid Review (Part 2 of 2)
trachomatis, Chlamydophila pp. 723-735;
696-712; Respiratory
Embryology pp. 26 1 hour
Rickettsia
pneumoniae overview; 10.6 -
& Chlamydophila (Part 1 of 2) pp. 683-695
Paracoccidioides brasiliensis; 602-603; Anatomy pp. 604- 25 1 hour
Rickettsia prowazekii; 10.7 - 2.1 - 610-617; Pathology pp. 618-
Malassezia furfur; 2.2 604; Physiology (Part 1 of 2)
Candida albicans; 3.2 -- Anatomy pp. 416-419;
629; Pharmacology pp. 630-
24 1.5 hours
Epidermophyton
Aspergillus fumigatus;spp., 3.3 - Physiology pp. 420-423; pp. 27 1 hour
441-444; Pharmacology
Rhizopus spp. (mucormycetes);
Cryptococcus neoformans (Part 1 Pathology (Part 1 of 2)pp.
pp.
(Picornaviridae); 1.5jirovecii;
- Hepatitis 445-454; Embryology 25 1.5 hours
3.5 - Pneumocystis 1.1A- 379-380; Physiology pp. 381-
virus (Picornaviridae); 1.6 - 368-369; Anatomy (Part 1 of 26 1 hour
Eastern/Western/Venezuelan 405-407;
385; Pharmacology
Pathology (Part 1 ofpp.
2)
Norovirus/Norwalk
equine encephalitis virus
virus, Rubella 408-411; Embryology pp. 24 1.5 hours
(Coronaviridae) (Part 2 of 2); 1.11
virus Physiology pp. 653-660;
HIV (Togaviridae);
-(Orthomyxoviridae);
Part 1: Overview 1.10 - 636-647; Anatomy
2.2 - Measles Pathology
Pharmacology
pp. 648-
pp. 679-682; 26 1 hour
pp. 661-678
(Retroviridae);
virus, mumps virus,1.12 -respiratory
HIV Part 2: Psychiatry (Part 1 of 2) pp. 26 1 hour
597-600; Molecular pp. 34-
virus, Rift Valley fever virus virus 575-596
syncytial virus, parainfluenza 45; Cellular pp. 46-51; 25 1 hour
(Bunyaviridae); 2.6 - Lymphocytic
Laboratory Techniques (Part
2 of 2) pp. 55-55; Genetics
1 & 2 (Herpesviridae); 3.2 -
pp. 56-64; Nutrition
Metabolism pp.2)65-
(Part 2 of pp. 26 1 hour
Epstein–Barr virus
zoster virus (Herpesviridae); 3.5 - 72; Metabolism (Part 1 of 2)
81-94; Basic Bateriology pp. 24 1 hour
HHV-6, roseola
3.8 - Human (Herpesviridae); 150; Mycology pp. 151-154;
papillomavirus 124-133 26 1.5 hours
B
(Papillomaviridae); 3.9 - 1.1 -
virus (Hepadnaviridae); Parasitology (Part 1 of 2) pp.
Giardia lamblia spp.; 2.1 -
Cryptosporidium Parasitology (Part 2 of 2) pp. 26 1 hour
186-186; Antimicrobials pp.
Toxoplasma gondii; 2.2cruzi;
2); 3.1 - Trypanosoma - 3.2 - Immunology (Part 2 of 2) pp. 25 1 hour
187-204; Immunology (Part
Trypanosoma
Babesia; 3.3 - brucei; 2.3 - Part 1; 101-122; Pathology (Part 1 of
Plasmodium 25 1.5 hours
Pathology (Part 2 of 2) pp.
Vaginalis; 5.1 - Enterobius
3.4 - Plasmodium Part 2: 2) pp. 205-207
Wuchereria
vermicularis,bancrofti,
AncylostomaOnchocerca 208-229; Pharmacology (Part 26 1 hour
Pharmacology (Part 2 of 2)
volvulus, Toxocara canis, Loa loa 1 of 2) pp. 231-234 24 1 hour
pp. 235-258
(tissue nematodes); 6.1 -
djust your plan for your weak areas, if you fall behind, need catch-up days, etc.

y FREE trial of the Cram Fighter study schedule planner at www.cramfighter.com. Good luck!
UWorld questions Book Study Hours Lecture Study Hours QBank Study Hours
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1
10 2 1 1

10 2 1 1
10 2 1 1
10 2 1 1

40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2

40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2

40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2

40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2

40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 3 1 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2

40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2
40 4 2 2